Global Myeloid Cells Targeting Therapeutics Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myeloid Cells Targeting Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Intravenous Injection
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Myeloid Cells Targeting Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncological Disorders
1.3.3 Rare Disorders
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Myeloid Cells Targeting Therapeutics Market Perspective (2020-2031)
2.2 Global Myeloid Cells Targeting Therapeutics Growth Trends by Region
2.2.1 Global Myeloid Cells Targeting Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Myeloid Cells Targeting Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Myeloid Cells Targeting Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Myeloid Cells Targeting Therapeutics Market Dynamics
2.3.1 Myeloid Cells Targeting Therapeutics Industry Trends
2.3.2 Myeloid Cells Targeting Therapeutics Market Drivers
2.3.3 Myeloid Cells Targeting Therapeutics Market Challenges
2.3.4 Myeloid Cells Targeting Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Myeloid Cells Targeting Therapeutics Players by Revenue
3.1.1 Global Top Myeloid Cells Targeting Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Myeloid Cells Targeting Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Myeloid Cells Targeting Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Myeloid Cells Targeting Therapeutics Revenue
3.4 Global Myeloid Cells Targeting Therapeutics Market Concentration Ratio
3.4.1 Global Myeloid Cells Targeting Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myeloid Cells Targeting Therapeutics Revenue in 2024
3.5 Global Key Players of Myeloid Cells Targeting Therapeutics Head office and Area Served
3.6 Global Key Players of Myeloid Cells Targeting Therapeutics, Product and Application
3.7 Global Key Players of Myeloid Cells Targeting Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Myeloid Cells Targeting Therapeutics Breakdown Data by Type
4.1 Global Myeloid Cells Targeting Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Myeloid Cells Targeting Therapeutics Forecasted Market Size by Type (2026-2031)
5 Myeloid Cells Targeting Therapeutics Breakdown Data by Application
5.1 Global Myeloid Cells Targeting Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Myeloid Cells Targeting Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Myeloid Cells Targeting Therapeutics Market Size (2020-2031)
6.2 North America Myeloid Cells Targeting Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Myeloid Cells Targeting Therapeutics Market Size by Country (2020-2025)
6.4 North America Myeloid Cells Targeting Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Myeloid Cells Targeting Therapeutics Market Size (2020-2031)
7.2 Europe Myeloid Cells Targeting Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Myeloid Cells Targeting Therapeutics Market Size by Country (2020-2025)
7.4 Europe Myeloid Cells Targeting Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Myeloid Cells Targeting Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Myeloid Cells Targeting Therapeutics Market Size (2020-2031)
9.2 Latin America Myeloid Cells Targeting Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Myeloid Cells Targeting Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Myeloid Cells Targeting Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Myeloid Cells Targeting Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Myeloid Cells Targeting Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Myeloid Cells Targeting Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Myeloid Cells Targeting Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ChemoCentryx
11.1.1 ChemoCentryx Company Details
11.1.2 ChemoCentryx Business Overview
11.1.3 ChemoCentryx Myeloid Cells Targeting Therapeutics Introduction
11.1.4 ChemoCentryx Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025)
11.1.5 ChemoCentryx Recent Development
11.2 Daiichi Sankyo
11.2.1 Daiichi Sankyo Company Details
11.2.2 Daiichi Sankyo Business Overview
11.2.3 Daiichi Sankyo Myeloid Cells Targeting Therapeutics Introduction
11.2.4 Daiichi Sankyo Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025)
11.2.5 Daiichi Sankyo Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Myeloid Cells Targeting Therapeutics Introduction
11.3.4 Gilead Sciences Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025)
11.3.5 Gilead Sciences Recent Development
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Details
11.4.2 Janssen Biotech Business Overview
11.4.3 Janssen Biotech Myeloid Cells Targeting Therapeutics Introduction
11.4.4 Janssen Biotech Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025)
11.4.5 Janssen Biotech Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Myeloid Cells Targeting Therapeutics Introduction
11.5.4 Roche Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025)
11.5.5 Roche Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Myeloid Cells Targeting Therapeutics Introduction
11.6.4 Pfizer Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025)
11.6.5 Pfizer Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Myeloid Cells Targeting Therapeutics Introduction
11.7.4 GlaxoSmithKline Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025)
11.7.5 GlaxoSmithKline Recent Development
11.8 Macrophage Pharma
11.8.1 Macrophage Pharma Company Details
11.8.2 Macrophage Pharma Business Overview
11.8.3 Macrophage Pharma Myeloid Cells Targeting Therapeutics Introduction
11.8.4 Macrophage Pharma Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025)
11.8.5 Macrophage Pharma Recent Development
11.9 Enlivex
11.9.1 Enlivex Company Details
11.9.2 Enlivex Business Overview
11.9.3 Enlivex Myeloid Cells Targeting Therapeutics Introduction
11.9.4 Enlivex Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025)
11.9.5 Enlivex Recent Development
11.10 Immune-Onc Therapeutics
11.10.1 Immune-Onc Therapeutics Company Details
11.10.2 Immune-Onc Therapeutics Business Overview
11.10.3 Immune-Onc Therapeutics Myeloid Cells Targeting Therapeutics Introduction
11.10.4 Immune-Onc Therapeutics Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025)
11.10.5 Immune-Onc Therapeutics Recent Development
11.11 Infinity Pharmaceuticals
11.11.1 Infinity Pharmaceuticals Company Details
11.11.2 Infinity Pharmaceuticals Business Overview
11.11.3 Infinity Pharmaceuticals Myeloid Cells Targeting Therapeutics Introduction
11.11.4 Infinity Pharmaceuticals Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025)
11.11.5 Infinity Pharmaceuticals Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Details
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Myeloid Cells Targeting Therapeutics Introduction
11.12.4 AstraZeneca Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025)
11.12.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Myeloid Cells Targeting Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Intravenous Injection
Table 3. Key Players of Oral
Table 4. Global Myeloid Cells Targeting Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Myeloid Cells Targeting Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Myeloid Cells Targeting Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Myeloid Cells Targeting Therapeutics Market Share by Region (2020-2025)
Table 8. Global Myeloid Cells Targeting Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Myeloid Cells Targeting Therapeutics Market Share by Region (2026-2031)
Table 10. Myeloid Cells Targeting Therapeutics Market Trends
Table 11. Myeloid Cells Targeting Therapeutics Market Drivers
Table 12. Myeloid Cells Targeting Therapeutics Market Challenges
Table 13. Myeloid Cells Targeting Therapeutics Market Restraints
Table 14. Global Myeloid Cells Targeting Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Myeloid Cells Targeting Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Myeloid Cells Targeting Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myeloid Cells Targeting Therapeutics as of 2024)
Table 17. Ranking of Global Top Myeloid Cells Targeting Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Myeloid Cells Targeting Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Myeloid Cells Targeting Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Myeloid Cells Targeting Therapeutics, Product and Application
Table 21. Global Key Players of Myeloid Cells Targeting Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Myeloid Cells Targeting Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Myeloid Cells Targeting Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Myeloid Cells Targeting Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Myeloid Cells Targeting Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Myeloid Cells Targeting Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Myeloid Cells Targeting Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Myeloid Cells Targeting Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Myeloid Cells Targeting Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Myeloid Cells Targeting Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Myeloid Cells Targeting Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Myeloid Cells Targeting Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Myeloid Cells Targeting Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Myeloid Cells Targeting Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Myeloid Cells Targeting Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Myeloid Cells Targeting Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Myeloid Cells Targeting Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Myeloid Cells Targeting Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Myeloid Cells Targeting Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Myeloid Cells Targeting Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Myeloid Cells Targeting Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. ChemoCentryx Company Details
Table 47. ChemoCentryx Business Overview
Table 48. ChemoCentryx Myeloid Cells Targeting Therapeutics Product
Table 49. ChemoCentryx Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025) & (US$ Million)
Table 50. ChemoCentryx Recent Development
Table 51. Daiichi Sankyo Company Details
Table 52. Daiichi Sankyo Business Overview
Table 53. Daiichi Sankyo Myeloid Cells Targeting Therapeutics Product
Table 54. Daiichi Sankyo Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Daiichi Sankyo Recent Development
Table 56. Gilead Sciences Company Details
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Myeloid Cells Targeting Therapeutics Product
Table 59. Gilead Sciences Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Janssen Biotech Company Details
Table 62. Janssen Biotech Business Overview
Table 63. Janssen Biotech Myeloid Cells Targeting Therapeutics Product
Table 64. Janssen Biotech Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Janssen Biotech Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Myeloid Cells Targeting Therapeutics Product
Table 69. Roche Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Myeloid Cells Targeting Therapeutics Product
Table 74. Pfizer Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. GlaxoSmithKline Company Details
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Myeloid Cells Targeting Therapeutics Product
Table 79. GlaxoSmithKline Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025) & (US$ Million)
Table 80. GlaxoSmithKline Recent Development
Table 81. Macrophage Pharma Company Details
Table 82. Macrophage Pharma Business Overview
Table 83. Macrophage Pharma Myeloid Cells Targeting Therapeutics Product
Table 84. Macrophage Pharma Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Macrophage Pharma Recent Development
Table 86. Enlivex Company Details
Table 87. Enlivex Business Overview
Table 88. Enlivex Myeloid Cells Targeting Therapeutics Product
Table 89. Enlivex Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025) & (US$ Million)
Table 90. Enlivex Recent Development
Table 91. Immune-Onc Therapeutics Company Details
Table 92. Immune-Onc Therapeutics Business Overview
Table 93. Immune-Onc Therapeutics Myeloid Cells Targeting Therapeutics Product
Table 94. Immune-Onc Therapeutics Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Immune-Onc Therapeutics Recent Development
Table 96. Infinity Pharmaceuticals Company Details
Table 97. Infinity Pharmaceuticals Business Overview
Table 98. Infinity Pharmaceuticals Myeloid Cells Targeting Therapeutics Product
Table 99. Infinity Pharmaceuticals Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Infinity Pharmaceuticals Recent Development
Table 101. AstraZeneca Company Details
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Myeloid Cells Targeting Therapeutics Product
Table 104. AstraZeneca Revenue in Myeloid Cells Targeting Therapeutics Business (2020-2025) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report


List of Figures
Figure 1. Myeloid Cells Targeting Therapeutics Picture
Figure 2. Global Myeloid Cells Targeting Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Myeloid Cells Targeting Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Intravenous Injection Features
Figure 5. Oral Features
Figure 6. Global Myeloid Cells Targeting Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Myeloid Cells Targeting Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Oncological Disorders Case Studies
Figure 9. Rare Disorders Case Studies
Figure 10. Myeloid Cells Targeting Therapeutics Report Years Considered
Figure 11. Global Myeloid Cells Targeting Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Myeloid Cells Targeting Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Myeloid Cells Targeting Therapeutics Market Share by Region: 2024 VS 2031
Figure 14. Global Myeloid Cells Targeting Therapeutics Market Share by Players in 2024
Figure 15. Global Top Myeloid Cells Targeting Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myeloid Cells Targeting Therapeutics as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Myeloid Cells Targeting Therapeutics Revenue in 2024
Figure 17. North America Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Myeloid Cells Targeting Therapeutics Market Share by Country (2020-2031)
Figure 19. United States Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Myeloid Cells Targeting Therapeutics Market Share by Country (2020-2031)
Figure 23. Germany Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Myeloid Cells Targeting Therapeutics Market Share by Region (2020-2031)
Figure 31. China Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Myeloid Cells Targeting Therapeutics Market Share by Country (2020-2031)
Figure 39. Mexico Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Myeloid Cells Targeting Therapeutics Market Share by Country (2020-2031)
Figure 43. Turkey Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. ChemoCentryx Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2020-2025)
Figure 47. Daiichi Sankyo Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2020-2025)
Figure 48. Gilead Sciences Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2020-2025)
Figure 49. Janssen Biotech Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2020-2025)
Figure 50. Roche Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2020-2025)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2020-2025)
Figure 53. Macrophage Pharma Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2020-2025)
Figure 54. Enlivex Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2020-2025)
Figure 55. Immune-Onc Therapeutics Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2020-2025)
Figure 56. Infinity Pharmaceuticals Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2020-2025)
Figure 57. AstraZeneca Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit